Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 26, 2020
Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models
Hui Wei, Hui-Liang Zhang, Xiao-Chuan Wang, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
March 14, 2022
Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
Wenting Hu, Zhuoqun Wang, Huiliang Zhang, et al.
Neurobiology of Aging
|
December 30, 2018
CIP2A-promoted astrogliosis induces AD-like synaptic degeneration and cognitive deficits
Yang-Ping Shentu, Wen-Ting Hu, Qing Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2021
Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias
Eleonora Mäkelä, Karolina Pavic, Taru Varila, et al.
Molecular Oncology
|
July 17, 2023
PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells
Oxana V Denisova, Joni Merisaari, Riikka Huhtaniemi, et al.
Cell Reports
|
August 4, 2015
Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative Proliferation
Kevin Myant, Xi Qiao, Tuuli Halonen, et al.
Molecular Cancer Therapeutics
|
April 1, 2022
Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype
Anna N Cvrljevic, Umar Butt, Kaisa Huhtinen, et al.
Cell Reports
|
July 19, 2018
CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease
Yang-Ping Shentu, Yuda Huo, Xiao-Long Feng, et al.
Science Translational Medicine
|
July 20, 2018
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
Otto Kauko, Caitlin M O'Connor, Evgeny Kulesskiy, et al.
Molecular Oncology
|
December 3, 2022
PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers
Anna Aakula, Aleksi Isomursu, Christian Rupp, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 26, 2020
Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models
Hui Wei, Hui-Liang Zhang, Xiao-Chuan Wang, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
March 14, 2022
Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
Wenting Hu, Zhuoqun Wang, Huiliang Zhang, et al.
Neurobiology of Aging
|
December 30, 2018
CIP2A-promoted astrogliosis induces AD-like synaptic degeneration and cognitive deficits
Yang-Ping Shentu, Wen-Ting Hu, Qing Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2021
Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias
Eleonora Mäkelä, Karolina Pavic, Taru Varila, et al.
Molecular Oncology
|
July 17, 2023
PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells
Oxana V Denisova, Joni Merisaari, Riikka Huhtaniemi, et al.
Cell Reports
|
August 4, 2015
Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative Proliferation
Kevin Myant, Xi Qiao, Tuuli Halonen, et al.
Molecular Cancer Therapeutics
|
April 1, 2022
Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype
Anna N Cvrljevic, Umar Butt, Kaisa Huhtinen, et al.
Cell Reports
|
July 19, 2018
CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease
Yang-Ping Shentu, Yuda Huo, Xiao-Long Feng, et al.
Science Translational Medicine
|
July 20, 2018
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
Otto Kauko, Caitlin M O'Connor, Evgeny Kulesskiy, et al.
Molecular Oncology
|
December 3, 2022
PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers
Anna Aakula, Aleksi Isomursu, Christian Rupp, et al.
Page
of 10